Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food effect study of tinlorafenib in healthy adults
NCT05349864Phase 1Completed
- Sponsor
- Pfizer
- Start
- Jun 2022
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tinlorafenib in solid tumor (2 arms), sponsored by Pfizer. Primary endpoints: Area Under the Plasma Concentration-Time Profile From Time Zero to the Time of the Last Quantifiable Concentration, Area Under the Plasma Concentration-Time Curve From Time Zero Extrapolated to Infinity and 1 more. Started Jun 2022; status: completed.
02
Drugs
tinlorafenib
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT05349864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05349864.